about
Emollients and moisturisers for eczema: abridged Cochrane systematic review including GRADE assessments.The International TREatment of ATopic Eczema (TREAT) Registry Taskforce: An Initiative to Harmonize Data Collection across National Atopic Eczema Photo- and Systemic Therapy Registries.Performance and Tolerability of the Moisturizers Cetaphil(®) and Excipial(®) in Atopic Dermatitis: What is the Evidence Based on Randomized Trials?Emollients and moisturisers for eczema.Barriers and Facilitators to eHealth Use in Daily Practice: Perspectives of Patients and Professionals in Dermatology.AGREE II assessments of recent acne treatment guidelines: how well do they reveal trustworthiness as defined by the U.S. Institute of Medicine criteria?Eczema treatment: it takes time to do no harm.Systemic immunomodulatory treatments for atopic dermatitis: protocol for a systematic review with network meta-analysisAtopic eczema: burden of disease and individual suffering - results from a large EU study in adultsOut-of-pocket Costs for Individuals with Atopic Eczema: A Cross-sectional Study in Nine European CountriesInterventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessmentsTREatment of ATopic eczema (TREAT) Registry Taskforce: consensus on how and when to measure the core dataset for atopic eczema treatment research registriesTREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczemaRosacea treatment guideline for the NetherlandsEczema and water hardness: another piece of the puzzle found?Publication of national dermatology guidelines as a Research Letter in the BJD: can less ever be enough?
P50
Q36354045-F30A128B-D730-4E90-87E7-E845EB5FA343Q36385357-E102FF64-B1AC-4174-AA89-292F77A8987BQ38732976-87961198-9DDB-4443-AE83-5A2886FB98FDQ38976344-DD6A555D-2CDA-4354-8B1A-1150B26CEAA8Q40502696-78E5E4EF-B192-4F57-8EF6-9B7B37E69ECCQ47332556-12FD536A-0424-4227-9FF9-DD062070506AQ48306297-FD870764-E447-41A9-B9F7-498F9640D807Q58694533-8A2F6460-30C0-4284-8780-E3A4CB3E9479Q90010496-45F96CF7-DF7A-4EC8-8A79-D57E5AC22FC2Q90303945-37C05941-3051-4EB5-A644-ACC6A1A44C86Q90751280-84674B2C-ABE6-4AB7-B563-482AEC8A34B7Q91344318-CE8AAE48-C335-4006-BEF6-622354C3280CQ92836216-477020EE-333C-4923-99A7-D6EF9B7A1804Q92866461-1A75E137-BA6D-4DD9-98C2-D97BF4551415Q93021049-01193F8A-1397-458F-89AB-581B1260E0DBQ96019774-9BDC8D07-E1A5-4BEF-B98E-AA9A040AF4F6
P50
description
researcher ORCID ID = 0000-0001-6884-8014
@en
wetenschapper
@nl
name
Bernd Wm Arents
@ast
Bernd Wm Arents
@en
Bernd Wm Arents
@nl
type
label
Bernd Wm Arents
@ast
Bernd Wm Arents
@en
Bernd Wm Arents
@nl
prefLabel
Bernd Wm Arents
@ast
Bernd Wm Arents
@en
Bernd Wm Arents
@nl
P106
P31
P496
0000-0001-6884-8014